Chengdu Yacht Bio-technology Co., Ltd

Chengdu Yacht Bio-technology Co.,Ltd, founded in 2004 and headquartered in Chengdu China, is a comprehensive pharmaceutical manufacturing company specializing in the R&D, production and sales of specialty APIs (including intermediates) and finished drugs.  Yacht's products are bio-synthesis and semi-synthesis APIs and high value-added finished dosage, covering the treatment fields of anti-infective, anti-fungal, anti-tumor, immunosuppressant, as well as metabolism etc. The core products are Daptomycin, Caspofungin acetate, Micafungin sodium, Everolimus, Dalbavancin hydrochloride. Yacht has constructed management system of R&D, commercialized production，and sales in whole pharmaceutical industrial chain. With rigorous quality management, strong process development capability and large-scale manufacturing capacity, Yacht has formed a core competitive advantage in the specialty API segmentation industry. The subsidiary Sichuan Novals Pharmaceuticals Co., Ltd was founded in 2010, and is located in Sichuan Tianfu New District with an area of 40000m2. Novals is mainly engaged in manufacturing various high-end APls, intermediates, and pharmaceutical excipients. Novals adheres to the principle of quality and service first and provides customers with high-quality products and solutions. The facility has passed GMP inspections by Japan PMDA and China NMPA.